Missing medicines
June 14, 2012
ONE in four people with type 2
diabetes do not take basal insulin
as prescribed, whilst more than a
third suffer from hypoglycemia,
according to a new study.
The Global Attitude of Patients
and Physicians survey, enrolled
3,042 people with type 2 diabetes
using insulin analog and 1,653
healthcare professionals across the
USA, Canada, Japan, Germany, UK
and Denmark, between January
and March 2012.
Key findings of the survey
included the fact that dosing
irregularities are common in people
with type 2 diabetes taking basal
insulin, as evidenced by the fact
that during a 30 day period 22% of
diabetics missed a dose, 24%
mis-timed a dose by more than two
hours and 14% reduced a basal
insulin dose.
In addition the researchers found
that self-treated hypoglycemia is a
significant management challenge
in type 2 diabetes with 36% of
those surveyed experiencing an
event during a 30 day period.
Interestingly, there was a
correlation between hypoglycemia
and dosing irregularities, with
those who missed a basal insulin
dose in the previous 30 days being
significantly more likely to report
self-treated hypoglycemia over the
same period.
"The challenges of addressing
dosing irregularities and self-treated
hypoglycemia are critical for
improving patient care as they
greatly impact the achievement of
optimal glycemic control,” said the
study’s lead researcher Dr Meryl
Brod.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Jun 12To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Jun 12
